521 related articles for article (PubMed ID: 21068522)
1. Prevalence of stroke/transient ischemic attack among patients with acute coronary syndromes in a real-world setting.
Deitelzweig SB; Ogbonnaya A; Berenson K; Lamerato LE; Costas JP; Makenbaeva D; Corbelli J
Hosp Pract (1995); 2010 Nov; 38(4):7-17. PubMed ID: 21068522
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
[TBL] [Abstract][Full Text] [Related]
3. Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome.
Bonafede M; Jing Y; Gdovin Bergeson J; Liffmann D; Makenbaeva D; Graham J; Deitelzweig SB
Hosp Pract (1995); 2011 Aug; 39(3):16-22. PubMed ID: 21881388
[TBL] [Abstract][Full Text] [Related]
4. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
Ducrocq G; Amarenco P; Labreuche J; Alberts MJ; Mas JL; Ohman EM; Goto S; Lavallée P; Bhatt DL; Steg PG
Circulation; 2013 Feb; 127(6):730-8. PubMed ID: 23277306
[TBL] [Abstract][Full Text] [Related]
5. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
Toth PP
Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
[TBL] [Abstract][Full Text] [Related]
6. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
Mitchell LB; Southern DA; Galbraith D; Ghali WA; Knudtson M; Wilton SB;
Heart; 2014 Oct; 100(19):1524-30. PubMed ID: 24860007
[TBL] [Abstract][Full Text] [Related]
7. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.
Burton TM; Lacey M; Liu F; Yu Y; Monsalvo ML; Lang K; Sander S
J Med Econ; 2012; 15(6):1217-25. PubMed ID: 22857539
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes, health resource use, and cost in patients with early versus late dual or triple anti-platelet treatment for acute coronary syndrome.
Friedman H; Mollon P; Lian J; Navaratnam P
Am J Cardiovasc Drugs; 2013 Aug; 13(4):273-83. PubMed ID: 23728829
[TBL] [Abstract][Full Text] [Related]
10. Emerging oral antiplatelet therapies for acute coronary syndromes.
Pollack CV
Hosp Pract (1995); 2010 Nov; 38(4):29-37. PubMed ID: 21068524
[TBL] [Abstract][Full Text] [Related]
11. Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data.
Diener HC; Bogousslavsky J; Brass LM; Cimminiello C; Csiba L; Kaste M; Leys D; Matias-Guiu J; Rupprecht HJ
Cerebrovasc Dis; 2004; 17(2-3):253-61. PubMed ID: 14981346
[TBL] [Abstract][Full Text] [Related]
12. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
[TBL] [Abstract][Full Text] [Related]
13. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
14. Validity of administrative data for identifying patients who have had a stroke or transient ischemic attack using EMRALD as a reference standard.
Tu K; Wang M; Young J; Green D; Ivers NM; Butt D; Jaakkimainen L; Kapral MK
Can J Cardiol; 2013 Nov; 29(11):1388-94. PubMed ID: 24075778
[TBL] [Abstract][Full Text] [Related]
15. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
16. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.
Packard KA; Campbell JA; Knezevich JT; Davis EM
Pharmacotherapy; 2012 Mar; 32(3):244-73. PubMed ID: 22392457
[TBL] [Abstract][Full Text] [Related]
17. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.
James SK; Storey RF; Khurmi NS; Husted S; Keltai M; Mahaffey KW; Maya J; Morais J; Lopes RD; Nicolau JC; Pais P; Raev D; Lopez-Sendon JL; Stevens SR; Becker RC;
Circulation; 2012 Jun; 125(23):2914-21. PubMed ID: 22572911
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
